Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 20.6B | 19.0B | 19.2B | 20.2B |
Cost of revenue | 11.2B | 10.5B | 11.9B | 11.7B |
Gross profit | 9.3B | 8.5B | 7.3B | 8.5B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 5.5B | 5.7B | 5.1B | 5.5B |
Operating income | 1.7B | 570M | 140M | 750M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 10M | 30M | 20M | 170M |
Other income expense | — | — | — | — |
Pretax income | 2.9B | 2.1B | 1.4B | 1.6B |
Tax provision | 770M | 530M | 330M | 420M |
Net income | 2.1B | 1.6B | 1.1B | 1.2B |
Basic EPS | — | 11.1 | 7.1 | 8.0 |
Diluted EPS | — | 11.1 | 7.1 | 8.0 |
Basic average shares | — | 147.0M | 147.1M | 146.9M |
Diluted average shares | — | 147.0M | 147.1M | 146.9M |
EBITDA | 3.6B | 2.9B | 2.1B | 2.5B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |